Boston Scientific rezum Series Скачать руководство пользователя страница 5

Boston S

cientific (Master Brand DFU 

Template 8.2677in x 1

1.6929in 

A4, 9223851

9A), eDFU

, MB, R

ez

ū

m, en, 50849555-0

1A

Black (K) ∆E ≤5.0

Post Procedure

1.  Remove the Delivery Device from the urethra.
2.  Remove the cystoscopic lens for cleaning and reprocessing.
3.  Transfer procedure summary information to a portable USB 

memory device (Optional).

4.  Disconnect the Delivery Device electrical cable from  

the Generator.

5.  Open roller pump door and remove Saline Flush Line  

from pump.

6.  Remove Syringe and Water Line from syringe cradle.
7.  Dispose of Delivery Device and Syringe.

Caution:

 After use, this product may be a potential biohazard. 

Handle and dispose of in accordance with acceptable medical 

practices and applicable local, state, and federal guidelines.

8.  Turn the Generator off.
9.  Disconnect the Generator from the electrical outlet.

METHOD FOR DRAINING THE BLADDER

If necessary during treatment, the bladder can be drained 

through the Delivery Device.
1.  Ensure needle is retracted.
2.  Place the tip of the Delivery Device in the bladder to drain.
3.  Unclamp the drain line.
4.  Remove scope lens to expedite draining of the bladder.
5.  Select Drain Bladder on Generator to reset Saline Instilled.
6.  When finished draining the bladder, reclamp the drain line.

METHOD FOR CLEARING VISUAL FIELD AND/OR REMOVING 

A CLOT

1.  To clear bubbles from the field of vision and/or to remove a 

clot, activate the Turbo Flush feature by double tapping and 

holding the Flush Activation Button.

2.  When visualization is cleared, release Flush Activation 

Button. Flush will run at normal rate the next time the Flush 

Activation Button is engaged.

METHOD FOR MANUAL NEEDLE RETRACTION

In the event the Needle Retraction Button fails to retract the 

needle fully into the Delivery Device shaft, follow the steps 

below to manually retract the needle into the Delivery Device 

shaft before removing the Delivery Device from the urethra. 

This should not occur under normal use and is designed only 

as a backup in case of device malfunction.
1.  Disconnect Delivery Device Electrical Cable from  

the Generator.

2.  Using a hemostat or other device, pull down and remove the 

release pin located below the nose cone to disengage the 

shaft assembly from the Delivery Device handle (Figure 15).

Figure 15. Pulling Down Release Pin. 

3.  Hold the shaft firmly in position and withdraw the handle 

just sufficiently to draw the needle into the shaft tip (1 inch 

minimum) (Figure 16).

Figure 16. Holding Shaft Steady in Patient, Withdraw the Handle Just 

Sufficiently to Draw the Needle into the Shaft Tip (1 inch minimum).

Figure 17. Holding Shaft Steady in Patient, Pull Needle Driver Out 

of Shaft to Retract Needle Into Tip.

Note:

 As the handle is being withdrawn, if the distal end of the needle 

body (in the handle) detaches from the handle and the proximal end 

of the needle is not drawn into the shaft tip, pull on the beige, right-

angled plastic tube protruding from the shaft to manually retract the 

proximal end of the needle into the shaft tip (Fig. 17).

4.  While maintaining the needle tip within the shaft, remove 

Delivery Device from patient.

5.  If treatment is incomplete, re-start procedure with new Delivery 

Device and complete procedure.

6.  Report all incidences of manual needle retraction to  

Boston Scientific Customer Service. Clean device and return  

to Boston Scientific.

Warning:

 Do not remove device from the patient if the needle 

is not fully retracted. In case of incomplete needle retraction, 

manually retract needle before removing the device from the 

patient. Do not attempt to reassemble device for reuse after 

manual needle retraction.

STORAGE, HANDLING, AND DISPOSAL
Rigid Cystoscope Lens

Refer to the rigid cystoscope lens packaging insert instructions for 

use for care, cleaning and handling.

Rez

ū

m™ Delivery Device

The Delivery Device is shipped sterile. If the package sterile barrier 

is broken or missing, do not use the product.
The Delivery Device must not be reused or re-sterilized. It is for 

single use only.
The Delivery Device is packaged for easy transfer to the sterile 

field. The Delivery Device should be handled with care at all times. 

The storage area should have good ventilation, store in a cool, dry, 

dark place.
After use, discard the Delivery Device in accordance with local 

environmental regulations for biohazards material.

Caution:

 The Delivery Device is intended for single-use only. 

Do not reuse, reprocess or resterilize the device. Reuse, 

reprocessing or resterilization may compromise the structural 

integrity of the device and/or create a risk of contamination of 

the device, which could result in patient injury or illness.

Rez

ū

m Generator

1.  Unplug the power cord and store the cord with the 

Generator.

2.  Clean the Generator as per the instructions found in the 

Rez

ū

m Operator’s Manual.

3.  Close the display screen to protect it from damage.
4.  Store the Rez

ū

m Generator in a safe, clean and dry 

location.

5.  To transport the Rez

ū

m Generator, use handle to carry.

Disposal of the Product, Accessories and Packing Materials

Dispose of all products, accessories and packaging materials  

in accordance with hospital, administrative and/or local 

government policy.

PIVOTAL CLINICAL STUDY SUMMARY
Efficacy

The Rez

ū

m II Study was a multicenter, randomized, controlled, 

double-blinded study comparing the improvement in BPH 

symptoms at baseline and at 3 months post-procedure, as 

measured by IPSS, for subjects in the Treatment Arm as 

compared to subjects in the Control Arm. The Treatment Arm 

consisted of subjects receiving injections of water vapor into 

targeted zones of the prostate. The Control Arm consisted of 

subjects receiving a rigid cystoscopy with simulated active 

treatment sounds. The Treatment Arm demonstrated clinically, 

and statistically, significant mean improvement as compared 

to the Control Arm. The difference between the two arms 

was highly significant and the pre-specified, 3-month primary 

endpoint was met (p < 0.0001). 
The graphs below summarize the Treatment Arm outcomes 

through 4 years for IPSS, Qmax, and Quality of Life.

Содержание rezum Series

Страница 1: ...e exterior of the Sterile Water Vial is not sterile and should not be placed in the sterile field Positioning Saline Flush Line in Saline Pump Reference indicators on Generator to ensure Saline Flush Line is positioned in the correct direction If Saline Flush Line is placed in a backwards direction within the Saline Pump saline will not flow during procedure Remaining Saline Level in Bag Care shou...

Страница 2: ...tray Topical antiseptic e g Betadine Patient drape Disposable underpads e g Chux Gauze squares Lidocaine gel anesthetic or water soluble lubricating gel Saline supply at room temperature 1 L 2 L 3 L 4 L 5 L or 500 ml IV pole for Saline supply 4 mm 30 degree 30 cm Storz or Richard Wolf rigid cystoscope lens Light source and cord Video camera and display recorder optional Drain bucket Hemostat Prepa...

Страница 3: ...sh Line is placed in a backwards direction within the Saline Pump saline will not flow during procedure 5 Close Saline Pump door prior to attaching Saline Flush Line tip to the Saline bag Note If Saline Flush Line tip is attached to Saline bag prior to placing Saline Flush Line in the Saline Pump and closing the Saline Pump door saline may leak 6 Remove cap from tip of Saline Flush Line and attach...

Страница 4: ...ry Device tip is proximal to the verumontanum and treat the bulk of the lateral lobe proximal to the verumontanum Advance the Delivery Device in 1 cm increments toward the bladder neck to deliver subsequent vapor treatments This may relax the tissue to allow the Delivery Device to reach the bladder neck If the Delivery Device still cannot reach the bladder neck treat the area that is proximal to t...

Страница 5: ...he shaft to manually retract the proximal end of the needle into the shaft tip Fig 17 4 While maintaining the needle tip within the shaft remove Delivery Device from patient 5 If treatment is incomplete re start procedure with new Delivery Device and complete procedure 6 Report all incidences of manual needle retraction to Boston Scientific Customer Service Clean device and return to Boston Scient...

Страница 6: ...Procedure or Device Related AEs Severity Resolved AEs Mild Moderate Severe Dysuria 17 14 4 0 97 Hematuria Gross 12 11 1 0 100 Hematospermia 6 6 1 0 100 Urinary Frequency 6 5 1 0 82 Decrease in Ejaculatory Volume 5 4 1 0 33 UTI Suspected 5 4 1 0 100 Urinary Retention 5 1 4 1 100 Urinary Urgency 5 3 2 0 78 Anejaculation 3 2 1 0 0 Terminal Dribbling 3 2 1 0 60 UTI Culture Proven 3 1 2 0 100 Epididymi...

Страница 7: ... M006D2201 003 G2200 003 GTIN 08714729992547 GTIN 0855357006003 Responsible Party U S Contact Information Boston Scientific Corporation 300 Boston Scientific Way Marlborough MA 01752 508 382 9555 www bostonscientific com FCC Compliance Statement This device complies with Part 18 of the FCC Rules For further information see FCC web site for a complete description of all requirements WARRANTY Boston...

Страница 8: ... REP Legal Manufacturer Boston Scientific Corporation 300 Boston Scientific Way Marlborough MA 01752 USA USA Customer Service 888 272 1001 Recyclable Package Australian Sponsor Address Boston Scientific Australia Pty Ltd PO Box 332 BOTANY NSW 1455 Australia Free Phone 1800 676 133 Free Fax 1800 836 666 AUS Do not use if package is damaged Argentina Local Contact ARG Para obtener información de con...

Отзывы: